Marshall Ken W.
Insider CIK 1740092 · AQST SVP, Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-08-09 | 2023-08-09 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-05-05 | 2023-05-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2023-03-09 | 2023-03-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-11-04 | 2022-11-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-03-10 | 2022-03-14 | 80,000 | — | $0 | 80,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-03-11 | 2021-03-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-18 | 45,400 | — | $0 | 45,400 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-09-18 | 2019-09-20 | 66,000 | — | $0 | 66,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-21 | 2018-12-03 | 1,445 | $10.15 | $14.7K | 1,445 | SEC↗ |